BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 22564468)

  • 1. Treatment eligibility in Alaska Native and American Indian persons with hepatitis C virus infection.
    Livingston SE; Townshend-Bulson LJ; Bruden DL; McMahon BJ; Homan CE; Gove JE; Deubner H; Bruce MG; Robinson RF; Gretch DR
    Int J Circumpolar Health; 2012 Apr; 71():1-7. PubMed ID: 22564468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing assessment and treatment for hepatitis C virus infection in illicit drug users: a novel model incorporating multidisciplinary care and peer support.
    Grebely J; Knight E; Genoway KA; Viljoen M; Khara M; Elliott D; Gallagher L; Storms M; Raffa JD; DeVlaming S; Duncan F; Conway B
    Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):270-7. PubMed ID: 20425880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus and human immunodeficiency virus coinfection in an urban population: low eligibility for interferon treatment.
    Fleming CA; Craven DE; Thornton D; Tumilty S; Nunes D
    Clin Infect Dis; 2003 Jan; 36(1):97-100. PubMed ID: 12491208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
    Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
    Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis, treatment, and follow-up of hepatitis C-virus related liver disease. Hungarian national consensus guideline].
    Hunyady B; Gervain J; Horváth G; Makara M; Pár A; Szalay F; Telegdy L; Tornai I
    Orv Hetil; 2014 Mar; 155 Suppl():3-24. PubMed ID: 24631886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatric comorbidity does not predict interferon treatment completion rates in hepatitis C seropositive veterans.
    Dollarhide AW; Loh C; Leckband SG; Endow-Eyer R; Robinson S; Meyer JM
    J Clin Gastroenterol; 2007 Mar; 41(3):322-8. PubMed ID: 17426475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation.
    Stravitz RT; Shiffman ML; Sanyal AJ; Luketic VA; Sterling RK; Heuman DM; Ashworth A; Mills AS; Contos M; Cotterell AH; Maluf D; Posner MP; Fisher RA
    Liver Transpl; 2004 Jul; 10(7):850-8. PubMed ID: 15237368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical presentation, outcome, and response to therapy among patients with acute exacerbation of chronic hepatitis C.
    Sagnelli E; Pisaturo M; Stanzione M; Messina V; Alessio L; Sagnelli C; Starace M; Pasquale G; Coppola N
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1174-1180.e11. PubMed ID: 23591280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reasons for HCV non-treatment in underserved African Americans: implications for treatment with new therapeutics.
    Schaeffer S; Khalili M
    Ann Hepatol; 2015; 14(2):234-42. PubMed ID: 25671833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between adherence to hepatitis C virus therapy and virologic outcomes: a cohort study.
    Lo Re V; Teal V; Localio AR; Amorosa VK; Kaplan DE; Gross R
    Ann Intern Med; 2011 Sep; 155(6):353-60. PubMed ID: 21930852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C treatment eligibility in an urban population with and without HIV coinfection.
    Adeyemi OM; Jensen D; Attar B; Ghaoui R; Gallagher M; Wolen D; Cotler SJ
    AIDS Patient Care STDS; 2004 Apr; 18(4):239-45. PubMed ID: 15142354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High uptake of hepatitis C virus treatment in HIV/hepatitis C virus co-infected patients attending an integrated HIV/hepatitis C virus clinic.
    Kieran J; Dillon A; Farrell G; Jackson A; Norris S; Mulcahy F; Bergin C
    Int J STD AIDS; 2011 Oct; 22(10):571-6. PubMed ID: 21998177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained virologic response to standard interferon or pegylated interferon and ribavirin in patients with hepatitis C virus genotype 5: systematic review and meta-analysis of ten studies and 423 patients.
    Devaki P; Jencks D; Yee BE; Nguyen MH
    Hepatol Int; 2015 Jul; 9(3):431-7. PubMed ID: 26016464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of treatment of hepatitis C virus infection in renal transplant recipients.
    Aljumah AA; Saeed MA; Al Flaiw AI; Al Traif IH; Al Alwan AM; Al Qurashi SH; Al Ghamdi GA; Al Hejaili FF; Al Balwi MA; Al Sayyari AA
    World J Gastroenterol; 2012 Jan; 18(1):55-63. PubMed ID: 22228971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and Clinical Management of Persons with Chronic Hepatitis C Virus Infection - Cherokee Nation, 2012-2015.
    Mera J; Vellozzi C; Hariri S; Carabin H; Drevets DA; Miller A; Reilley B; Essex W; Gahn D; Lyons L; Leston J; Ward JW
    MMWR Morb Mortal Wkly Rep; 2016 May; 65(18):461-6. PubMed ID: 27172175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virological response in patients with hepatitis C virus genotype 1b and a high viral load: impact of peginterferon-alpha-2a plus ribavirin dose reductions and host-related factors.
    Yamada G; Iino S; Okuno T; Omata M; Kiyosawa K; Kumada H; Hayashi N; Sakai T
    Clin Drug Investig; 2008; 28(1):9-16. PubMed ID: 18081356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the natural history and outcome of treatment for Asian and non-Asian hepatitis C-infected patients.
    Lawson A;
    J Viral Hepat; 2011 Jul; 18(7):e270-7. PubMed ID: 21138506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role and possibilities of natural interferon treatment in chronic hepatitis C: experience with natural interferon treatment for patients barred from combined antiviral therapy because of the STOP rule].
    Horváth G; Tolvaj G; Halász T; Stotz G
    Orv Hetil; 2007 Aug; 148(33):1545-50. PubMed ID: 17686672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.